Enveric Biosciences Inc (ENVB) Company Sales Volume

Enveric Biosciences (ENVB) is developing partnerships with clinics to create psilocybin-based therapies. The company's aggregate sales level, as shown on this GURU.Markets chart, confirms the growth trend, where 0.00 represents the current metric level. This paves the way for market monopolization through proprietary formulas and the introduction of innovative non-hallucinogenic antidepressants during the active R&D phase.

ENVB - Enveric Biosciences, Inc. Revenue and Sales Volume over the range 07/04/2022 - 11/14/2026

Comprehensive metric breakdowns and analytics for Enveric Corp (ENVB)

- market price and analyst price targets:

Market Price enveric.com|ENVB - Price Target Chart

- market capitalization details:

Market Capitalization Enveric Corp|ENVB - Real Price to Acquire Entire Company

- issuer book value statistics:

Net Assets per Single Share Enveric Biosciences|ENVB - Book Capitalization|Market-to-Book Ratio enveric.com|ENVB - Aggregate Company Assets

- debt obligations and liquidity statistics:

- earnings and market ratios statistics:

ENVB - Net Profit|Company Profit Forecast Enveric Biosciences|ENVB - Price to Earnings Ratio|Projected Price to Earnings Ratio Enveric Biosciences Inc|ENVB - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio Enveric Biosciences Inc|ENVB - Operating profit EBITDA|Net earnings per share for the last 12 months Enveric Biosciences|ENVB - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months enveric.com|ENVB - Earnings growth in current year|Expected net earnings per share growth next year Enveric Biosciences

- company sales and revenue statistics:

ENVB - Company Revenue|Company Revenue Forecast Enveric Biosciences|ENVB - P/S Multiple|Forward Price-to-Revenue Multiple Enveric Biosciences Inc

Summary company analysis:ENVB Enveric Biosciences, Inc.

For the biotech sector, characterized by high R&D uncertainty and a lack of guaranteed revenue, monitoring operational inflows is critical for assessing capital burn rates. This algorithm aggregates daily cash flows from commercial activities, allowing investors to objectively measure real demand for Enveric Biosciences (ENVB) products by analyzing the company's sales history for trend sustainability.

Competing companies